Hsa-miR-183-5p modulates cell adhesion by repression of ITGB1 expression in prostate cancer
Prostate cancer is a major health problem worldwide. MiR-183 is an oncomiR and a candidate biomarker in prostate cancer, affecting various pathways responsible for disease initiation and progression. We sought to discover the most relevant processes controlled by miR-183 through an unbiased transcri...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , |
| التنسيق: | article |
| اللغة: | الإنجليزية |
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://hdl.handle.net/20.500.12008/41376 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: Hsa-miR-183-5p modulates cell adhesion by repression of ITGB1 expression in prostate cancer
- An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
- Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth
- vtRNA2-1/nc886 produces a small RNA that contributes to its tumor suppression action through the microRNA pathway in prostate cancer
- Estudio de genes blanco candidatos de HSA-MIR-183-5P involucrados en la adhesión celular en cáncer de próstata
- Transcriptome-wide analysis of microRNA–mRNA correlations in tissue identifies microRNA targeting determinants
- Thick calculations of the prostate lodge